To further investigate the relevant molecular mechanism of E2F6 associated with the survival of HNSCC patients, the top 200 co-expressed genes associated with E2F6 in HNSCC were used to perform KEGG and GO pathway enrichment analyses. The gene discussed is E2F6; the disease is head and neck squamous cell carcinoma.